IP Library Granted Patent US 8,580,576
Granted Patent B2
US 8,580,576 · App. 13/198,510 · Granted Nov 12, 2013

Method for bodily fluid sample transfer during analyte determination

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,576
App. No.
13/198,510
Granted
Nov 12, 2013
Kind
B2
Abstract

A method for the transfer of a bodily fluid sample (such as a whole blood sample) during the determination of an analyte (e.g., glucose) in the bodily fluid sample includes applying the bodily fluid sample to a sample collection reservoir of an analytical test strip (for example, an electrochemical-based analytical test strip). During such application, the sample collection reservoir is isolated from fluid communication with a determination chamber of the analytical test strip. The analytical test strip is subsequently inserted into a test meter such that the sample collection reservoir is placed into fluid communication with the determination chamber and such that at least a portion of the bodily fluid sample is consequentially transferred from the sample collection reservoir to the determination chamber. The method further includes determining the analyte in the bodily fluid sample transferred to the determination chamber.

Claims (16)

1. A method for the transfer of a bodily fluid sample during the determination of an analyte in the bodily fluid sample, the method comprising:

applying a bodily fluid sample to a sample collection reservoir of an analytical test strip, the sample collection reservoir being isolated from fluid communication with a determination chamber of the analytical test strip;

inserting the analytical test strip into a test meter such that the sample collection reservoir is placed into fluid communication with the determination chamber and such that at least a portion of the bodily fluid sample is consequentially transferred from the sample collection reservoir to the determination chamber; and

determining an analyte in the bodily fluid sample transferred to the determination chamber.

2. The method of claim 1 further comprising:

pre-treating, following application of the bodily fluid sample and prior to the determining of the analyte, the applied bodily fluid sample in the sample collection reservoir.

3. The method of claim 2 wherein the pre-treating includes one of a chemical pre-treatment of the applied bodily fluid sample and an enzymatic pre-treatment of the applied bodily fluid sample.

4. The method of claim 1 wherein the sample collection reservoir is a capillary sample collection reservoir and the determination chamber is a capillary determination chamber.

5. The method of claim 4 wherein at least one dimension of the capillary sample chamber is in the range of 0.15 mm to 0.5 mm and one dimension of the capillary determination chamber is in the range of 0.025 mm to 0.18 mm.

6. The method of claim 5 wherein the inserting step is such that at least a portion of the bodily fluid sample is transferred from the capillary sample collection reservoir to the capillary determination chamber by capillary action upon insertion of the analytical test strip into the test meter.

7. The method of claim 1 wherein the analytical test strip is configured such that the sample collection reservoir and the determination chamber are moveable with respect to one another; and

wherein the inserting step establishes fluid communication between the sample collection chamber and determination chamber by movement of the sample collection reservoir and determination chamber with respect to one another.

8. The method of claim 7 wherein the sample collection reservoir is slidable with respect to the determination chamber and wherein insertion of the analytical test strip into the test meter serves to slide the sample collection chamber such that the sample collection chamber is in fluid communication with the determination chamber.

9. The method of claim 1 wherein the analytical test strip is an electrochemical-based analytical test strip and includes at least one electrode in the determination chamber.

10. The method of claim 1 wherein the analytical test strip is configured to include dual sample collection reservoirs.

11. The method of claim 1 wherein the bodily fluid sample is a whole blood sample and the analyte is glucose.

Assignments (15)
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 051050/0413 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2011
From: QURAISHI, KHALID R.; MATZINGER, DAVID
To: CILAG GMBH INTERNATIONAL
Reel/Frame 026729/0600 →